BMJ  2003;326:1367 (21 June), doi:10.1136/bmj.326.7403.1367

Primary care

Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study

¹ Department of Dermatology, University Hospitals Coventry and Warwickshire NHS Trust, Walsgrave Hospital, Coventry CV2 2DX, ² Ziekenhuis Nij Smellinghe, Compagnonsplein 1, 9202 NN Drachten, Netherlands, ³ Praxis Dr Golsch, Bayerstrasse 45, D-80335 Munich, Germany, ⁴ Hudpoliklinikken, Teatergaten 37, N-5010 Bergen, Norway, ⁵ Clinique Ste Elisabeth, Place Louise Godin 15, B-5000 Namur, Belgium, ⁶ Institute of Medical and Surgical Dermatology, University of Parma, I-43100 Parma, Italy, ⁷ clinical development and medical affairs GlaxoSmithKline, Research and Development, Greenford, Middlesex UB6 0HE

Objective To explore the efficacy and safety of fluticasone propionate, cream and ointment, applied twice weekly in addition to maintenance treatment with emollients, in reducing the risk of relapse of chronic recurrent atopic dermatitis.

Design Randomised, double blind, parallel group study of 20 weeks' duration.

Setting Dermatology outpatient clinics (6 countries, 39 centres).

Participants Adult (aged 12-65) patients with moderate to severe atopic dermatitis who were experiencing a flare.

Methods Participants applied fluticasone propionate (0.05% cream or 0.005% ointment; once or twice daily) regularly for four weeks to stabilise their condition. The patients whose disease was brought under control then continued into a 16 week maintenance phase, applying emollient on a daily basis with a bath oil as needed and either the same formulation of fluticasone propionate or its placebo base (emollient alone) twice weekly to the areas that were usually affected.

Main outcome measure Time to relapse of atopic dermatitis during maintenance phase.

Results 376 patients entered the stabilisation phase, and 295 continued into the maintenance phase. After 16 weeks in the maintenance phase, the disease remained under control in 133 patients (87 using fluticasone propionate twice weekly, 46 using emollient alone), 135 (40 fluticasone propionate, 95 emollient) had experienced a relapse, and 27 had discontinued. Median time to relapse was six weeks for emollient alone compared with more than 16 weeks for additional fluticasone propionate. Patients who applied fluticasone propionate cream twice weekly were 5.8 times less likely (95% confidence interval 3.1 to 10.8, P < 0.001) and patients using fluticasone propionate ointment 1.9 times less likely (1.2 to 3.2, P=0.010) to have a relapse than patients applying emollient alone. The groups showed no differences in adverse events.

Conclusion After atopic dermatitis had been stabilised the addition of fluticasone propionate twice weekly to maintenance treatment with emollients significantly reduced the risk of relapse.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Atopic and non-atopic eczema

Sara Brown and Nick J Reynolds
BMJ 2006 332: 584-588. [Extract] [Full Text] [PDF]

Fluticasone propionate reduces risk of relapse in atopic dermatitis
BMJ 2003 326: 0. [Full Text]

This article has been cited by other articles:

• Bieber, T. (2008). Atopic Dermatitis. NEJM 358: 1483-1494 [Full text]  
• Langan, S. M., Thomas, K. S., Williams, H. C. (2006). What is meant by a "flare" in atopic dermatitis?: a systematic review and proposal.. Arch Dermatol 142: 1190-1196 [Abstract] [Full text]  
• Brown, S., Reynolds, N. J (2006). Atopic and non-atopic eczema. BMJ 332: 584-588 [Full text]  
• Charman, C. R., Venn, A. J., Williams, H., Bigby, M. (2005). Measuring Atopic Eczema Severity Visually: Which Variables Are Most Important to Patients?. Arch Dermatol 141: 1146-1151 [Abstract] [Full text]  
• Williams, H. C. (2005). Atopic Dermatitis. NEJM 352: 2314-2324 [Full text]  
• Williams, H. C. (2004). Twice-Weekly Topical Corticosteroid Therapy May Reduce Atopic Dermatitis Relapses. Arch Dermatol 140: 1151-1152 [Full text]  
• Atherton, D. J (2003). Topical corticosteroids in atopic dermatitis. BMJ 327: 942-943 [Full text]  

Rapid Responses:

Read all Rapid Responses

John Berth-Jones et al

Jeremy Stephen Chowings
bmj.com, 2 Jul 2003 [Full text]

topical maintenance treatment in atopic dermatitis in children

Egidio Barbi, et al.
bmj.com, 15 Jul 2003 [Full text]

Online poll

Find out more >>